- Home
- OFS vs COYA Comparison
OFS vs COYA Comparison
Compare OFS & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OFS
- COYA
- Stock Information
- Founded
- OFS 2001
- COYA 2020
- Country
- OFS United States
- COYA United States
- Employees
- OFS N/A
- COYA N/A
- Industry
- OFS Finance/Investors Services
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- OFS Finance
- COYA Health Care
- Exchange
- OFS Nasdaq
- COYA Nasdaq
- Market Cap
- OFS 115.2M
- COYA 104.3M
- IPO Year
- OFS 2012
- COYA 2022
- Fundamental
- Price
- OFS $8.92
- COYA $5.60
- Analyst Decision
- OFS
- COYA Strong Buy
- Analyst Count
- OFS 0
- COYA 4
- Target Price
- OFS N/A
- COYA $16.25
- AVG Volume (30 Days)
- OFS 61.5K
- COYA 70.0K
- Earning Date
- OFS 10-31-2024
- COYA 11-06-2024
- Dividend Yield
- OFS 15.74%
- COYA N/A
- EPS Growth
- OFS N/A
- COYA N/A
- EPS
- OFS N/A
- COYA N/A
- Revenue
- OFS $49,799,000.00
- COYA $9,554,315.00
- Revenue This Year
- OFS N/A
- COYA N/A
- Revenue Next Year
- OFS N/A
- COYA $87.80
- P/E Ratio
- OFS N/A
- COYA N/A
- Revenue Growth
- OFS N/A
- COYA N/A
- 52 Week Low
- OFS $7.75
- COYA $4.75
- 52 Week High
- OFS $12.41
- COYA $10.69
- Technical
- Relative Strength Index (RSI)
- OFS 71.88
- COYA 36.62
- Support Level
- OFS $8.08
- COYA $5.40
- Resistance Level
- OFS $8.72
- COYA $6.44
- Average True Range (ATR)
- OFS 0.20
- COYA 0.35
- MACD
- OFS 0.05
- COYA -0.02
- Stochastic Oscillator
- OFS 90.20
- COYA 17.78
About OFS OFS Capital Corporation
OFS Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its business objective is to generate current income and capital appreciation by investing in middle-market companies in the United States. The company focuses on investments in senior secured loans, including first lien, second lien, and unitranche loans, as well as subordinated loans and, to a lesser extent, warrants, and other equity securities.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.